Benlysta (belimumab) - Progressive Multifocal Leukoencephalopathy Reported In Patients - For The Public

BENLYSTA Recall Summary BENLYSTA (belimumab), a medication used to treat certain autoimmune conditions, is being recalled across Canada because cases of progressive multifocal leukoencephalopathy (a serious brain infection) have been reported in patients taking this drug. The recall affects all patients in Canada who are currently using or have used this medication. Health Canada is alerting the public to this safety concern involving the drug.

Reason

Product safety

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2014-04-28

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/cc3dff9b-6e7f-4e5b-ad94-9e4c0675e700